Evidence map›Paper›PMID 29979642›Full record

Trial reportLGBT health2018

Increasing Human Papillomavirus Vaccination Among Young Gay and Bisexual Men: A Randomized Pilot Trial of the Outsmart HPV Intervention.

Paul L Reiter, Mira L Katz, José A Bauermeister, Abigail B Shoben, Electra D Paskett, Annie-Laurie McRee

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in LGBT health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Efficacy of the Outsmart HPV Intervention: A Randomized Controlled Trial to Increase HPV Vaccination among Young Gay, Bisexual, and Other Men Who Have Sex with Men.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paul L Reiter1 Division of Cancer Prevention and Control, College of Medicine, The Ohio State University , Columbus, Ohio.
Mira L Katz1 Division of Cancer Prevention and Control, College of Medicine, The Ohio State University , Columbus, Ohio.
José A Bauermeister4 Department of Family and Community Health, University of Pennsylvania School of Nursing , Philadelphia, Pennsylvania.
Abigail B Shoben2 Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio.
Electra D Paskett1 Division of Cancer Prevention and Control, College of Medicine, The Ohio State University , Columbus, Ohio.
Annie-Laurie McRee5 Division of General Pediatrics and Adolescent Health, University of Minnesota Medical School , Minneapolis, Minnesota.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
Increasing HPV Vaccine Coverage among Young Adult Gay and Bisexual MenR21CA194831 · NCI · OHIO STATE UNIVERSITY · PI MCREE, ANNIE-LAURIE, REITER, PAUL L · 2015 to 2016
$383k
NCI NIH HHS P30 CA016058NCI NIH HHS R21 CA194831
6 · The paper itself

Abstract

purposeThe study purpose was to pilot test a web-based human papillomavirus (HPV) vaccination intervention among young gay and bisexual men (YGBM).

methodsIn 2016, we recruited 150 unvaccinated YGBM aged 18-25 years from the United States. We randomized participants to the Outsmart HPV intervention or a control group.

resultsHPV vaccine initiation was higher among the intervention group than the control group (45% vs. 26%; odds ratio [OR] = 2.34, 95% confidence interval [CI]: 1.18-4.67). We observed a trend toward higher HPV vaccine completion among the intervention group (11% vs. 3%; OR = 4.24, 95% CI: 0.87-20.66).

conclusionsOutsmart HPV is a promising strategy for increasing HPV vaccination among YGBM.

Indexed as

AdolescentAdultBisexualityHealth PromotionHomosexuality, MaleHumansInternetMalePapillomavirus InfectionsPapillomavirus VaccinesPilot ProjectsProgram EvaluationUnited StatesVaccinationYoung AdultPapillomavirus VaccinesHPVHPV vaccineinterventionsexual minority men

Identifiers

PMID29979642
PMCPMC6034390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.